car-tcr

Oncology
CAR-TCR 2023 – Jonathan Wofford

CAR-TCR 2023 – Jonathan Wofford

In order for cell therapies to scale effectively, the industry is clamouring for standardisation around things like manufacturing and treatment administration.

Oncology
CAR-TCR 2023 – Mindy Miller

CAR-TCR 2023 – Mindy Miller

As more cell therapies are approved and the category emerges, there’s also an increased need for the technology that enables cell therapy development.

Oncology
CAR-TCR 2023 – Matt Lakelin

CAR-TCR 2023 – Matt Lakelin

Innovative, advanced therapies have enormous promise, but also come with a host of logistical problems that innovators underestimate at their own peril.

Oncology
CAR-TCR 2023 – Tim McGuire

CAR-TCR 2023 – Tim McGuire

As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.